District of Columbia Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 7 (88% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 2,499
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 96.13%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 108
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 97.62%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 3.24% 0.93%
White, Hispanic/Latino Patients 12.24% 7.41%
Black/African American, Non-Hispanic/Latino Patients 53.10% 26.85%
Black/African American, Hispanic/Latino Patients 0.52% 0.00%
Asian Patients3 0.56% 0.00%
American Indian/Alaska Native Patients3 0.48% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.12% 0.00%
Patients with More than one race3 3.00% 1.85%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 10.52% 1.85%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.68% 58.33%
Unreported/Refused to Report Race and Ethnicity 12.53% 2.78%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,012
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 98.57%
COVID-19 Immunization Series Completed 902
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 98.51%
COVID-19 Immunization Series Additional 32
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 84.00%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 1.19% 1.33% 12.50%
White, Hispanic/Latino Patients 11.17% 13.30% 0.00%
Black/African American, Non-Hispanic/Latino Patients 51.28% 52.22% 40.62%
Black/African American, Hispanic/Latino Patients 0.99% 0.67% 3.12%
Asian Patients3 0.00% 0.55% 0.00%
American Indian/Alaska Native Patients3 0.79% 0.44% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.30% 0.11% 0.00%
Patients with More than one race3 2.17% 3.55% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 14.92% 17.18% 21.88%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.98% 1.55% 12.50%
Unreported/Refused to Report Race and Ethnicity 15.22% 9.09% 9.38%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 0.00%
1 to 24 Hours 14.29%
More Than 24 Hours 85.71%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 14.29%
Staffing to administer the vaccine 42.86%
Vaccine confidence 42.86%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 14.29%
None 14.29%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 57.14%
Average Percent of Health Center Visits Conducted Virtually 35.00%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 42.86%
Number of Mobile Van Sites 0
Number of Pop-up Clinics 3
Number of School-Based Vaccination Sites 1

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 14.29%
Refer patients to another organization that provides monoclonal antibody therapies 57.14%
None 28.57%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 14.29%
Patient awareness/education 0.00%
Staffing capacity 0.00%
Therapy administration/onsite logistics 14.29%
Other 0.00%
None 71.43%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021